Post Essential Thrombocythemia Myelofibrosis

general

Myelofibrosis that develops in a patient with history of essential thrombocythemia.

42

Centers

23

Active Trials

Cancer Funding

Specific Cancer Types(1)

Top Centers for Post Essential Thrombocythemia Myelofibrosis(42)

Ranked by research excellence score (trials · grants · publications). Methodology →

#CenterScore
1
NCI Comprehensive
High-Volume Research Center
72.1
2
NCI Comprehensive
High-Volume Research Center
72.1
3
High-Volume Research Center
72.1
4
NCI Comprehensive
Active Research Program
61.4
5
NCI Comprehensive
Active Research Program
61.4
6
NCI Comprehensive
Active Research Program
61.4
7
NCI Comprehensive
Active Research Program
61.4
8
NCI Comprehensive
Active Research Program
61.4
961.4
10
NCI Comprehensive
Active Research Program
61.4
11
NCI Clinical
Active Research Program
61.4
12
NCI Comprehensive
Active Research Program
61.4
13
Active Research Program
61.4
14
Cedars-Sinai CancerLos Angeles, CA
Active Research Program
61.4
15
NCI Comprehensive
Active Research Program
61.4
16
NCI Comprehensive
Active Research Program
61.4
17
Fox Chase Cancer CenterPhiladelphia, PA
NCI Comprehensive
Active Research Program
61.4
18
Active Research Program
61.4
19
Active Research Program
61.4
20
Active Research Program
61.4
21
NCI Comprehensive
40.5
22
NCI Comprehensive
40.5
23
NCI Comprehensive
40.5
24
NCI Comprehensive
40.5
2540.5
26
NCI Comprehensive
40.5
27
NCI Comprehensive
40.5
28
NCI Clinical
40.5
29
NCI Comprehensive
40.5
30
NCI Comprehensive
40.5
3140.5
3240.5
3340.5
3440.5
3540.5
3640.5
3740.5
3840.5
3940.5
4040.5
4140.5
42
BC CancerVancouver, BC
40.5

Research tier badges reflect trial volume, NIH grant funding, and publication impact — not clinical outcomes or patient satisfaction. Learn about our methodology →